The QualityStocks Daily Monday, September 24th, 2018

Today's Top 3 StockMarketWatch

Schaeffer's (AMRN) +314.72%

MarketClub Analysis (SAEX) +284.34%

QualityStocks (MOMT) +94.77%

The QualityStocks Daily Stock List

Bion Environmental Technologies, Inc. (BNET)

TopPennyStockMovers, SECFilings.com News, Wall Street Resources, OTC Stock Review, and Stock Guru reported previously on Bion Environmental Technologies, Inc. (BNET), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bion Environmental Technologies, Inc. is a developer of advanced livestock waste treatment and resource recovery technology. The Company’s patented, next-generation technology provides verified comprehensive treatment of animal waste from large-scale livestock production facilities. Bion Environmental Technologies has its corporate office in Crestone, Colorado, and its administrative office in Old Bethpage, New York. 

The Company’s technology platform attains significant reductions in environmental impacts. This includes nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, and pathogens in the waste stream. This is while improving resource and operational efficiencies via the recovery of valuable byproducts.

Bion’s technology platform is a modular system. It can be configured in an array of ways, depending on farm- and region-specific requirements. The system creates new revenue sources and opportunities for the producer.

The Company’s treatment solutions are a combination of biological, mechanical, as well as thermal processes. These are proven in commercial operations. They have been accepted by the EPA (Environmental Protection Agency), the USDA (United States Department of Agriculture), and other regulatory agencies.

Bion’s 2nd generation (2G) Comprehensive Environmental Management System removes up to 95 percent of the nutrients from the livestock waste effluent. It considerably decreases air emissions, including ammonia (as great as 90 percent or more), greenhouse gases, hydrogen sulfide, VOC’s and others. This system extracts renewable energy from the waste stream in the form of cellulosic biomass.

In July of this year, Bion Environmental Technologies announced that it filed a continuation of its September 2015 patent for a livestock ammonia recovery process. This process converts the ammonia into stable ammonium bicarbonate. This filing will provide broadened protection for improvements to the technology platform that will enable naturally-occurring ammonia and carbon dioxide in the waste stream to be captured, separated, distilled, recombined, and also concentrated into a solid (crystal) ammonium bicarbonate product.

Bion Environmental Technologies’ anticipation is that the ammonium bicarbonate produced in its system can be certified for use in organic production. Organic certification for the Company’s ammonium bicarbonate will result in considerably higher values than chemically-produced alternatives. Bion’s anticipation is that the leftover residual solids, which contain the remaining nitrogen, and also salts and minerals, can also undergo processing to qualify for organic use as a soil amendment product, depending on market values.

Bion Environmental Technologies, Inc. (BNET), closed Monday's trading session at $0.76, up 2.70%, on 1,700 volume with 3 trades. The average volume for the last 3 months is 8,517 and the stock's 52-week low/high is $0.419/$0.959.

chart

Sport Endurance, Inc. (SENZ)

Stock Traders Chat, HotOTC, Simply Best Penny Stocks, Top Best Pennystocks, BullRally, CoolPennyStocks, Promotion Stock Secrets, Stock Beast, StockRockandRoll, Open Water Investments, OTC Picks, Penny Invest, Stock Rich, StockEgg, StockMister, 24-7 Stock Alert, Global Equity Report, and Penny Stock Explosion reported previously on Sport Endurance, Inc. (SENZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sport Endurance, Inc. develops, markets, and distributes nutritional supplement products across the U.S. Its goal is to improve health through providing quality and effective nutritional supplements. All Sport Endurance brand products are manufactured in the U.S. in Food and Drug Administration (FDA)-inspected facilities with strict quality control that follows Good Manufacturing Practices (GMP). Sport Endurance is based in New York City and the Company’s shares trade on the OTCQB.

Sport Endurance’s main emphasis is on three areas of health, which most directly impact the lives of many active adults. These are Total Wellness, Performance, and Recovery. Sport Endurance has launched its web portal to market men’s health products direct to consumers.

Regarding Sport Endurance’s supplements, they are natural supplements and contain no ingredients that would require a prescription. The all-natural dietary supplements meet wellness needs without using harsh synthetic chemicals.

The Company has launched a new direct to consumer nutritional supplement product named Ultra Peak T. This is a natural testosterone booster. The design of it is to help men over 30 overcome declining testosterone levels. Ultra Peak T includes Fenugreek Seed; Forskolin; Mucuna Pruriens Seed (Velvet Bean); Vitamin D3; and Zinc.

Sport Endurance also has its Sports Leg and Lung Formula product. Sports Leg and Lung Formula is a performance-amplifying workout drink. The Company says that this product can benefit all active adults through reducing the discomfort of muscle burn and delaying muscle fatigue.

Ingredients in Sports Leg and Lung Formula include CarnoSyn® beta-alanine; L-Taurine, and natural caffeine. A new pre-workout nutritional supplement product, it is a drink powder designed to improve performance for active adults across a number of athletic activities.

According to a 2016 report, published by Grand View Research, the expectation is that the dietary supplements market will reach USD 278.02 billion by 2024. Sports nutrition is expected to be worth USD 37.16 billion.

Sport Endurance, Inc. (SENZ), closed Monday's trading session at $0.30, up 7.14%, on 108 volume with 2 trades. The average volume for the last 3 months is 1,258 and the stock's 52-week low/high is $0.205/$1.20.

chart

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported previously on AXIM Biotechnologies, Inc. (AXIM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company centering on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market unique solutions through research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. is a major investor in AXIM. OTCQB-listed, AXIM Biotechnologies is based in New York, New York.

AXIM’s concentration is on innovative proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is currently no effective treatment. The Company is advancing its patented controlled-release cannabinoid gum in studies encompassing a number of indications. AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants.

AXIM Biotechnologies’ pipeline of Intellectual Property (IP) protected cannabinoid-based products additionally include MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. This pioneering invention is on path to be fully registered by the EMA and the Food and Drug Administration (FDA) by the end of 2017. It is the world’s first patented cannabinoid controlled-release chewing gum.

The Company’s products also include RENECANN™ - the world’s first cannabigerol (CBG)-based skincare product line. Furthermore, its products include ORAXIMAX™ - the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the lessening of intraocular pressure and for the relief of conjunctivitis.

AXIM® Biotechnologies earlier entered clinical trials at Wageningen University in the Netherlands for the treatment of irritable bowel syndrome (IBS) with AXIM's CanChew Plus® cannabidiol (CBD) gum. AXIM announced that it received approval from the Medical Ethical Committee (METC) at Wageningen University for the trial using controlled-release hemp oil CBD chewing gum with patients suffering from IBS.

AXIM Biotechnologies announced recently that it filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469. This is a patent of invention, which involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment. In addition, the chewing gum may be used for the treatment of chronic pain.

AXIM Biotechnologies has entered into a Clinical Study Agreement (CSA) with the University of British Columbia to start a clinical trial with its CanChew Plus® cannabidiol (CBD) chewing gum product to treat drug-induced psychosis in adult patients. The University will work with Health Canada and its own ethics board to design the trial that will take place at the University of British Columbia, and will demonstrate the efficacy of AXIM Biotechnologies’ chewing gum product composed of 50mg CBD to treat drug-related psychosis.

AXIM’S IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in different stages of approval. AXIM now has registered 18 trademarks nationally and worldwide, with five more trademark applications pending all founded on products formulated and developed by AXIM Biotechnologies.

AXIM Biotechnologies, Inc. (AXIM), closed Monday's trading session at $2.10, up 6.76%, on 180,987 volume with 379 trades. The average volume for the last 3 months is 94,293 and the stock's 52-week low/high is $1.70/$10.29.

chart

International Isotopes, Inc. (INIS)

SmallCapVoice and Orbit Stocks reported earlier on International Isotopes, Inc. (INIS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

International Isotopes, Inc. manufactures a comprehensive collection of nuclear medicine calibration and reference standards, and an assortment of cobalt-60 products, including teletherapy sources. The OTCQB-listed Company also provides a broad array of radiological field services on a contract basis to clients. Additionally, International Isotopes provides a wide-ranging selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. International Isotopes has its corporate office in Idaho Falls, Idaho.

The Company is working to advance its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility in Lea County, which is roughly 15 miles west of Hobbs, New Mexico. The new facility will be on a 640-acre site. The Company’s belief is that this new commercial facility will provide a first-rate commercial opportunity.

International Isotopes holds patents that give it exclusive rights for the Fluorine Extraction Process (FEP). This process produces high value, high purity fluoride gasses in union with uranium de-conversion. The Company exclusively owns the patents for the fluorine extraction process.

International Isotopes has developed a unique process to convert depleted uranium tails (the by-product produced from the enrichment of uranium) to ultra-high purity, high value industrial fluoride products. The Company’s’ business segments include the Depleted Uranium De-Conversion and Fluorine Extraction Process (FEP) Project; Radiochemicals for Cancer Treatment; Nuclear Medicine Reference and Calibration Standards; Medical Teletherapy Products, AOS Series Type B (U) Transportation Containers, and Transportation Services.

International Isotopes’ de-conversion process will convert the DUF6 by-product (or tails) from uranium enrichment operations into depleted uranium tetrafluoride (DUF4). The Company will then employ its patented FEP technology to extract fluorine from the DUF4 for use in the manufacture of specialty, high-value fluoride gases.

This past August, International Isotopes announced that a group of buyers acquired all the units of RadQual, LLC not already held by the Company. The buying group consists of a group of affiliates of International Isotopes, including the present Chairman of the Board, the former Chairman of the Board, and the Chief Executive Officer of International Isotopes. The group has acquired roughly 75 percent of the member units of RadQual. International Isotopes still retains its 25 percent ownership in RadQual.

After this purchase, International Isotopes was voted by the new members to become the main managing member of RadQual. It will be responsible for oversight of all business activities and management of RadQual.

Recently, International Isotopes announced that Dr. Robert W. Atcher, PhD, MBA, FSNMMI accepted a position on the Company's Board of Directors. Dr. Atcher recently retired from Los Alamos National Laboratory. He worked for more than two decades while there on different medical applications for isotopes. At present, Dr. Atcher serves as the President of the Education and Research Foundation for the Society of Nuclear Medicine and Molecular Imaging.

International Isotopes, Inc. (INIS), closed Monday's trading session at $0.0699, up 0.72%, on 34,000 volume with 6 trades. The average volume for the last 3 months is 37,232 and the stock's 52-week low/high is $0.0509/$0.111.

chart

Mobiquity Technologies, Inc. (MOBQ)

PennyStocks24, PennyPickAlerts, Penny Stock Circle, 1-2-3 Stock Alerts, StockRockandRoll, PennyStockLocks.com, ResearchOTC, Stock Commander, SmallCapVoice, and StockMister reported earlier on Mobiquity Technologies, Inc. (MOBQ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Mobiquity Technologies, Inc. operates a national location-based mobile advertising network. This network has developed a consumer-focused proximity network. Mobiquity Networks is a wholly-owned subsidiary of Mobiquity Technologies. Mobiquity Networks is the largest network of retail mall-based mobile advertising beacons in America. Mobiquity Networks is a next generation mobile location data intelligence and marketing company. Mobiquity Technologies is based in Garden City, New York.

Mobiquity Networks provides precise, unique, at-scale location based data and insights on consumers' real world behavior and trends. This is for use in marketing and research.

Mobiquity Technologies has exclusive agreements in hundreds of premier U.S. shopping malls. Its integrated group of unique location-based mobile advertising technologies enables retail and entertainment brands to execute personalized and contextually relevant experiences. This boosts brand awareness and incremental revenue.

Mobiquity Technologies is continuing to work to expand its location-based mobile advertising solutions to create "smart malls" in retail destinations throughout the U.S. employing Bluetooth-enabled iBeacon technology. By way of its subsidiaries, the Company provides brand marketing, advanced integrated marketing platforms, mobile marketing, social networks, Website development, and digital media solutions. It provides brand analysis and development, Website analysis and development, database analysis and building, and integrated marketing campaigns using direct mail, email marketing, mobile marketing, promotional products, and other mediums.

Furthermore, Mobiquity Technologies provides a proprietary Web development platform and delivers a content management system that puts content control back into the clients’ hands. The Company also provides hyper-local mobile marketing solutions. This includes a location-based marketing tool, which delivers digital content to Bluetooth or Wi-Fi enabled devices.

In June 2017, Mobiquity Networks announced the launch of the Passage Platform. This is its newly enhanced mobile device location platform. The new Passage Platform provides a significant leap ahead in the way marketers will be able to optimize active campaigns by measuring visits in real time.

This platform provides contextual and actionable insights. It enables marketers to more deeply engage with their most valuable consumers.

The Passage Platform provides a direct connection and deep understanding of consumers’ visitation behavior and engagement. The next generation business intelligence will enable store owners to enhance the in-store experiences and marketers their advertising strategy to increase visits.

In July of this year, Mobiquity Networks announced a new member to its team, Mr. Yuan Zhao. Mr. Zhao has a first-rate background in computer and data sciences. He joins the Mobiquity Networks development team as lead data scientist.

Mr. Zhao’s main goal will be enhancing Mobiquity’s Passage Platform with analytics and machine learning applications to further enrich data for customers. He comes to the Company from the IBM Watson Research Center, where he specialized in Geo-spatial Data and Audience Insights.

Mobiquity Technologies, Inc. (MOBQ), closed Monday's trading session at $0.0995, up 10.56%, on 47,349 volume with 11 trades. The average volume for the last 3 months is 116,962 and the stock's 52-week low/high is $0.013/$0.119.

chart

Surna, Inc. (SRNA)

Actual Gains, Hot Stock Profits, PennyStockRumors.net, DSR News, PricelessPennyStocks, Value Penny Stocks, Ascending Stocks, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, Marketbeat.com, CFN Media Group, Cannabis Financial Network News, PHUB News, SmallCapVoice, Greenbackers, OTC Stock Review, and Market Wire Stocks reported on Surna, Inc. (SRNA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. The Company develops unique technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. Surna’s mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with an emphasis on disruptive technology, equipment, and related support services. The Company’s aim is to dominate the infrastructure, growing, and support side of the worldwide cannabis industry.

Surna has its head office in Boulder, Colorado. The Company is a technology enterprise that engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA). At present, it specializes in commercial indoor cannabis cultivation.

Surna’s business model excludes the production or sale of marijuana. Surna develops cutting-edge technologies and products. The foundation of its current revenue stream is on its chief product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. Through its wholly-owned subsidiary, Hydro Innovations, Surna provides a complete line of commercial and small business indoor agriculture equipment.

Surna has its signature water-cooled climate control platform. It has filed a provisional patent application encompassing enhancements to its proprietary Climate Control Systems and Methods used in indoor gardens. The patent covers an industrial process that provides electricity, heating, and cooling while using the resulting carbon-dioxide (CO2) produced as a nutrient for the plants.

The Company’s intention is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. The system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Recently, Surna announced the launch of a new website and brand strategy to reflect its increasing position as a go-to solutions provider and the increasing impact its technology is having on the cultivation industry. The Company has become a leader for indoor growth cultivation via its expertise and technology developments in climate control and biosecurity systems.

Brandy Keen, Surna’s Sr. Technical Advisor and Co-Founder will be speaking on the topic of cannabis energy and water conservation solutions that produce greater yield at the following upcoming conferences in October. One is the Sustainability Symposium in Denver, Colorado on October 16th. The other is the CannaGrow Expo in Denver on October 28th.

Surna, Inc. (SRNA), closed Monday's trading session at $0.156, up 3.04%, on 319,954 volume with 104 trades. The average volume for the last 3 months is 451,316 and the stock's 52-week low/high is $0.094/$0.485.

chart

Where Food Comes From, Inc. (WFCF)

The Bowser Report, SmallCapVoice, Marketbeat.com, and Wyatt Investment Research reported earlier on Where Food Comes From, Inc. (WFCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Where Food Comes From, Inc. (d.b.a. IMI Global, Inc.) is a trusted resource for third party verification of food production practices. The Company supports greater than 10,000 farmers, ranchers, processors, retailers, distributors, and restaurants with a broad array of value-added services through its IMI Global, International Certification Services, Validus Verification Services, and Sterling Solutions units. Where Food Comes From is headquartered in Castle Rock, Colorado.

The Company's Where Food Comes From® retail and restaurant labelling program uses the verification of product attributes to connect consumers to the sources of the food they purchase via product labelling and web-based information sharing and education. Utilizing QR code technology, consumers can speedily access information regarding the producers behind their food.

Where Food Comes From has a solutions portfolio that encompasses beef, pork, poultry, lamb, dairy, eggs, and organic. The Company’s solutions portfolio includes offerings ranging from source and age, non-hormone and humane handling to organic, non-GMO (Genetically Modified Organism) and gluten free.

Its Sterling Solutions is a foremost provider of third-party verification services in the western U.S. Sterling Solutions serves large dairies, calf ranches, and cattle operations. It has more than 10 years of on-farm auditing experience. Sterling Solutions operates as a wholly-owned subsidiary of Where Food Comes From.

Where Food Comes From’s Validus Verification Services is a leader in independent certification of socially responsible production practices encompassing pork, poultry, as well as dairy products. Validus Verification Services is a wholly-owned subsidiary of the Company.

Where Food Comes From has acquired a 60 percent interest in privately held SureHarvest, Inc. SureHarvest is a top provider of agri-food sustainability solutions. SureHarvest provides an extensive variety of sustainability and farming MIS solutions, certification and compliance management, and a host of professional services.

Where Food Comes From has acquired privately held A Bee Organic, a USDA Accredited Certification Agency. A Bee Organic provides more than 125 customers with National Organic Program (NOP) certifications for hydroponic, aquaponic, in-ground and wild crops. This includes avocados, blueberries, citrus and stone fruits, greens, and manzanita.

Earlier this month, Where Food Comes From (d.b.a. IMI Global) announced its role as exclusive provider of third-party verifications for Ben & Jerry's Caring Dairy Standards. Under the Caring Dairy Standards program, dairy farmers that supply Ben & Jerry's with milk and cream must comply with three core areas of focus. These are Cow Care, Planet Stewardship, and Farmer livelihoods.

Cow Care involves animal care, well-being and herd management. Planet Stewardship covers an assortment of sustainable farming techniques. Farmer Livelihoods ensures safe dignified conditions for all involved on the farm. Where Food Comes From will conduct on-farm audits with Ben and Jerry's dairy suppliers to confirm compliance to these standards.

Where Food Comes From, Inc. (WFCF), closed Monday's trading session at $2.46, up 1.65%, on 3,000 volume with 4 trades. The average volume for the last 3 months is 15,161 and the stock's 52-week low/high is $1.76/$3.50.

chart

Freedom Leaf, Inc. (FRLF)

CFN Media Group, SmallCapVoice, Promotion Stock Secrets, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a top go-to resource in the cannabis, medical marijuana, as well as industrial hemp industry. The Company engages in mergers and acquisitions (M&A’s) in the marijuana industry. This includes incubation/acceleration and spin offs of new marijuana/hemp related companies. The Company does not handle, grow, sell, or disperse marijuana.

Freedom Leaf targets acquisitions of high growth and niche companies. Its business strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development. OTCQB-listed, Freedom Leaf has its corporate office in Las Vegas, Nevada.

The Company’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-changing and developing cannabis, medical marijuana, and industrial hemp industry.

The content Freedom Leaf produces and curates chiefly attracts industry professionals, including lawyers, legislators, activists, entrepreneurs, and people active in the business of cannabis and industrial hemp. The Freedom Leaf enterprise has become a leader in media production and distribution for the cannabis/hemp industry.

Freedom Leaf has acquired LaMarihuana.com. This is the Spanish Speaking community's foremost cannabis website. As part of this acquisition, Freedom Leaf acquired www.Marihuana-Medicinal.com. This is the largest Medical Cannabis information website in Spanish.

In late August, Freedom Leaf reported major developments in its Spanish acquisition, Green Market Europe (GME), in combination with University Miguel Hernández in Elche, Spain. Freedom Leaf and GME signed a Letter of Intent (LOI) for Freedom Leaf to acquire 100 percent of GME's IP, projects, and assets.

Freedom Leaf paid the cash stipulated in the contract as a deposit of the full transaction. Freedom Leaf has agreed to expand two additional growing operations worldwide before the end of 2019 to maximize the skills and the potential of staff. GME facilities include a 21,000-sq. ft. light deprivation greenhouse, which allows increasing the number of crops per year, a 43,000-sq. ft. greenhouse and indoor growing facility for Genetic research.

Freedom Leaf will be making presentations at two major financial conferences this month, at the New West Summit in Oakland, California (Oct. 13, 14, 15), and at the Alternative Asset ReLeaf Summit (Oct. 23) in Las Vegas, Nevada.

Freedom Leaf, Inc. (FRLF), closed Monday's trading session at $0.16175, up 3.22%, on 403,534 volume with 73 trades. The average volume for the last 3 months is 534,456 and the stock's 52-week low/high is $0.0265/$0.4719.

chart

DroneGuarder, Inc. (DRNG)

Insider Financial, InvestorsHub, OTC Markets, Barchart, StreetRegister.com, 4-Traders, and Emerging Growth.com reported on DroneGuarder, Inc. (DRNG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DroneGuarder, Inc. focuses on commercializing a drone enhanced home security system as a turnkey solution. The design of the Company’s DroneGuarder Mobile App is to let users have peace of mind within arms length, whether they are in their home or not. Established in San Francisco in 2017, DroneGuarder lists on the OTC Markets Group’s OTCQB. An early stage security and surveillance enterprise, the Company is headquartered in London, England.

DroneGuarder’s solution is app-based. It includes a drone, infrared camera, as well as an Android mobile app component. Upon an alarm being triggered, the DroneGuarder™ will immediately take off from a wireless charging pad.

The DroneGuarder™ assists in protecting against intruders. Upon an intruder being detected on the sensor net, one can have the drone fly to the event location.

Once there, one can use the built-in microphone to issue a harsh warning to scare away intruders. If that fails, the high-quality HD film captured of the intruder can be uploaded to the cloud and forwarded to law enforcement agencies.

A user can download the DroneGuarder™ security app for their phone through the Google Play Store or AppStore. In addition, upon purchasing a DroneGuarder subscription, a user can access the cloud service. The DroneGuarder can work on any Android device with a screen –smartphones, tablets, and also embedded Android devices.

An array of DJI drones is available and compatible with the DroneGuarder system. The design of the drones is to respond to commands from a user’s smart phone, and its native remote. This enables one to give it basic orders from anywhere.

This past November, Drone Guarder announced that it is partnering with Swellpro Ltd. of China. The Company has decided to use Swellpro as its drone supplier.

The Swellpro drone provides patented design and technology. Swellpro’s Splash Drones are waterproof. They can land and take off on water and with their waterproof cameras can stream live video from under water. They can operate in high winds and have carbon fiber rotors.

DroneGuarder said that these abilities and functions meet the product requirements the Company is looking for in its products, DG Rescue and DG Intruder.

DroneGuarder’s intention is to work jointly to imbed its scanning AI image recognition technology into Swellpro’s SD5 drone platform. This will enable the DG Rescue to autonomously grid search for victims in a search area and alert the rescue crews by way of GPS location and streaming video where the victims are. DroneGuarder will be jointly developing DG Intruder with Swellpro utilizing all the same technology, however it will be app based.

DroneGuarder, Inc. (DRNG), closed Monday's trading session at $0.0125, up 1.46%, on 49,000 volume with 11 trades. The average volume for the last 3 months is 159,756 and the stock's 52-week low/high is $0.10/$0.429.

chart

HCi Viocare (VICA)

CEO.ca, MarketWatch, and Financial Times reported earlier on HCi Viocare (VICA), and we also report on the Company, here at the QualityStocks Daily Newsletter.

HCi Viocare concentrates on the development and marketing of prosthetics and orthotics. The Company has a strong pipeline of near-market to research-stage technologies. Established in 2007, it previously went by the name China Northern Medical Device, Inc. It changed its name to HCi Viocare in March of 2014. HCi Viocare has its executive office in Athens, Greece, and its research and development (R&D) center in Glasgow, Scotland, United Kingdom (UK).

The Company’s business model consists of creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and developing a broad portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system. The clinics will operate according to British and International standards. They will provide independent and personalized quality of care for its patients. The first HCi Viocare clinic has been operating since September of 2015 in Glasgow.

HCi Viocare has two fully owned subsidiaries. One is HCi Viocare Technologies and the other is HCi Viocare Clinics. HCi Viocare Technologies is developing hardware solutions aiming to empower the user through providing on demand information and enhancing living quality.

The R&D center is working on a large portfolio of progressive, leading-edge, and disruptive technologies in the Digital Health, Prosthetics, and Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing fields. The Company has developed an inventive sensing technology with the brand name Flexisense™.

Flexisense™ technology is the next generation of sensing technologies for wearable devices. Flexisense™ is a unique sensing technology. It measures pressure and shear forces. Furthermore, it provides on demand information wirelessly. Flexisense can be incorporated in a broad spectrum of applications.

HCi Viocare Technologies has developed a new application for its sensing technology Flexisense™, now for automotive tires. Flexisense™ applied to tires can monitor, in real time, tire deformation and actual traction between the tire and the ground. Flexisense™ feeds back information to the vehicle's CPU. This lets the vehicle adjust to changing road and weather conditions. Flexisense™ also significantly increases safety and performance.

Yesterday, HCi Viocare announced that its Management, acknowledging the great advantages of Blockchain technology, decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. In addition, this team will develop a proprietary Blockchain based system for handling and storing the data produced from the medical applications of its Flexisense™ technology.

HCi Viocare (VICA), closed Monday's trading session at $0.80, up 5.96%, on 6,353 volume with 8 trades. The average volume for the last 3 months is 2,496 and the stock's 52-week low/high is $0.60/$2.76.

chart

MoneyOnMobile, Inc. (MOMT)

MarketWatch, InvestorsHub, Marketwired, Seeking Alpha, Barchart, TradingView, YCharts, 4-Traders, OTC Markets, Stockopedia, The Street, Stockflare, and Morningstar reported on MoneyOnMobile, Inc. (MOMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, MoneyOnMobile, Inc. is India's largest mobile payment platform. The Company facilitates easy, safe, and secure financial transactions to millions of Indians. MoneyOnMobile’s central belief is in providing service to the unbanked consumer, by means of Financial Inclusion and self-dependence.

The Company continually innovates to provide a range of unique solutions together with its continuous first-rate 24 x 7 transactional convenience via a simple SMS, Application and Web Portal. MoneyOnMobile is based in Dallas, Texas, and Mumbai, India.

The Company has authorization by the Reserve Bank of India (RBI) to set up a semi closed payment system in India that enables registered users to purchase goods, products, and services from registered Merchants. MoneyOnMobile provides an extensive range of services on a real-time basis, irrespective of geography, time, and mobile operator.

The Company’s services include money transfer, mobile recharge, bill payment, DTH recharge, train tickets, flight tickets, hotel booking, and online shopping. The Company has designed MoneyOnMobile to work across all mobile phone handsets. This is from the most basic to the most advanced.

In early September 2017, MoneyOnMobile announced that it processed greater than one million domestic money transfer transactions in August of 2017. August was the first calendar month in which the Company processed over one million domestic transfers.

Recently, MoneyOnMobile announced that August 2017 Revenue was up 30 percent over July of this year. The Company’s total monthly Revenue has increased by 291 percent since February. Its ATM and domestic remittance Revenue lines have increased 44 percent over the last 90 days (as of September 21, 2017).

Recently, MoneyOnMobile announced an agreement with ShopClues to enable the in-store purchase of ShopClues products utilizing the MoneyOnMobile platform at any of MoneyOnMobile's participating 335,000 retailers. ShopClues is one of India's largest e-commerce marketplaces.

Mr. Harold Montgomery, MoneyOnMobile’s Chairman and Chief Executive Officer, said, "Our strength lies in our pan-India retailer network, because it enables MoneyOnMobile to provide financial services to the remotest parts of India. This agreement opens access to the growing e-commerce market for the unbanked and the underbanked in India."

More than 2000 company ATMs have been installed throughout India in the first half of 2017. The Company announced that it recently served its 200 millionth cumulative unique phone number.

MoneyOnMobile, Inc. (MOMT), closed Monday's trading session at $1.08, up 94.77%, on 210,564 volume with 412 trades. The average volume for the last 3 months is 31,838 and the stock's 52-week low/high is $0.15/$14.39.

chart

Abattis Bioceuticals Corp. (ATTBF)

Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, Stockgoodies, Cannabis Financial Network News, Greenbackers, PennyStocks24, and Information Solutions Group reported earlier on Abattis Bioceuticals Corp. (ATTBF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a specialty, vertically-integrated biotechnology company. It aggregates, incubates, integrates, and invests in the botanical drug development industry. The Company’s divisions include Biocell Labs, Inc. and Vergence Sales & Marketing, Inc. Through these, the Company develops and licenses natural health products. In addition, its other divisions are Northern Vine Canada, Inc.; North American Bioextracts, Inc.; and Biocube Green Grow Systems Corp. Abattis Bioceuticals has its headquarters in Vancouver, British Columbia.

Abattis has capabilities that support the production and extraction of botanical ingredients for its products; one of which includes cannabis. The Company develops and licenses natural health products, medicines, extractions, and ingredients - some of which will contain cannabinoid compounds.  These are for the biologics, nutraceutical, bioceutical, and cosmetic markets. Furthermore, Abattis has a broad pipeline of high-quality products and intellectual property (IP) for the fast-growing botanical drug market.

Abattis Bioceuticals’ products and services include Botanical Blends & Formulas; CBD Ingredients; Functional Foods & Beverages; Research and Development (R&D); Analytical Services; and Pharma & Nutraceuticals. It has received a Natural Product Number (NPN) approval for Phyto(NOS). This NPN allows it to manufacture and sell Phyto(NOS) in Canada.

Phyto(NOS) has applications in a broad array of food, beverage, and nutraceutical products. Phyto(NOS) is an all-natural, patent-pending formulation. It naturally supports nitric oxide (a vasodilator) levels in the blood stream, supports nitric oxide production, and provides antioxidants.

Abattis Bioceuticals and Northern Vine entered into a Binding Memorandum of Agreement with Experion Biotechnologies to acquire up to 100 percent of Experion Biotechnologies, Inc.  Abattis Management has been centering their efforts on its Northern Vine Lab buildout after receiving their controlled substance dealers license (CSL) last year. Northern Vine Labs has the required licenses and controls in place to legally possess and work with the raw herb (cannabis) and its active ingredients.

Northern Vine will provide analytical R&D and quality control testing on a large assortment of cannabis based products, screening for cannabinoids, terpenes, microbiological contaminants, pesticides and residual solvents. The license also permits it to formulate new products for licensed producers in Canada.

Abattis Bioceuticals signed an exclusive distribution agreement with Suzhou Raybot Material Tech Corp. The Agreement permits Abattis to use Raybot's proprietary extraction technology and to exclusively sell the extraction equipment and services.

Raybot has developed a proprietary technology that uses industrial column chromatography to extract and separate a broad spectrum of materials, in a continuous, closed loop system.

Recently, Abattis Bioceuticals announced that its subsidiary, Northern Vine Canada, officially launched its flagship laboratory, having completed its initial successful test analysis. Northern Vine obtained a Health Canada Dealers' License pursuant to the provisions of the Controlled Drugs and Substances Act and the Narcotic Control Regulations. Northern Vine started taking samples from select Licensed Producers (LPs). It is building a sales force to aggressively grow its client base.

Abattis Bioceuticals Corp. (ATTBF), closed Monday's trading session at $0.14, up 6.06%, on 2,000,109 volume with 504 trades. The average volume for the last 3 months is 1,672,285 and the stock's 52-week low/high is $0.075/$0.744.

chart

Pacific Green Technologies, Inc. (PGTK)

Value Penny Stocks, WINNINGOTC, TryBestPennyStocks.biz, Wall Street Mover, Journal Transcript, InvestorSoup, SuperStockTips, Stock Preacher, Equity Observer, Jet-Life Penny Stocks, SMS Penny Picks, Beacon Equity Research, eliteotc.com, Penny Stocks Finder, Penny Stock Craze, SmallCapAllStars, The Street, and Wall Street Beauties reported on Pacific Green Technologies, Inc. (PGTK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Pacific Green Technologies, Inc. focuses on addressing the world’s need for cleaner and more sustainable energy. The Company’s strategy is to build, through organic development and acquisition, a portfolio of patented competitive progressive technologies designed to meet increasingly stringent environmental standards. Pacific Green Technologies China Limited (PGTC) is a subsidiary of Pacific Green Technologies, Inc. Pacific Green Technologies is based in San Jose, California.

Pacific Green Technologies China Limited (PGTC) has a Commercial Joint Venture Agreement (JV) with POWERCHINA SPEM Co., Limited. The JV Agreement sets out the terms for PGTC and POWERCHINA SPEM to co-operate exclusively in China for 10 years to develop the ENVI-Clean™ and ENVI-Pure™ emission control system to become the market leader in the Coal Fired Power, Steel Works, Cement Works, as well as Waste to Energy industry sectors.

Pacific Green Technologies has its Envi-Marine™ system. This is a seawater scrubber. Envi-Marine™ takes an alternative approach to seawater scrubbing through using the Envi-Clean™ inventive turbulent scrubbing head to provide interactive contact between the seawater and the exhaust gas in a turbulent zone containing a high amount of surface area for gas/liquid absorption.

Pacific Green’s ENVI-Clean™ is a patented Emissions Control System. The design of it is to remove pollutants from flue gases. ENVI-Clean™ is suitable for the removal of acid gases and particulate matter from high volume processes.

In addition, the ENVI-Pure™ system is a refined version of the ENVI-Clean™ system, designed to remove a wider variety of contaminants with very high efficiency as required by Waste to Energy (WtE) and Biomass power plants.

Pacific Green Technologies earlier signed a Memorandum of Understanding (MOU) with POWERCHINA SPEM Co., Limited to incorporate a new company. Pacific Green will own 50.1 percent and POWERCHINA SPEM 49.9 percent.

Initially, the jointly owned company will market Pacific Green's patented ENVI-Systems™ Technology for removal of noxious gases. It will then look to acquire licenses for more complementary technologies to market in China and Southeast Asia.

Earlier this month, Pacific Green Technologies announced that its subsidiary Pacific Green Technologies Marine Limited signed a brokerage agreement with Poten & Partners to assist Pacific Green Technologies in marketing its marine industry leading ENVI-Marine™ Exhaust Gas Scrubbing System. Poten & Partners provides ship and commodity brokerage, consulting, business intelligence and commercial advisory services to its clients.

Installing Exhaust Gas Scrubbing Systems permits ship owners and charterers to continue using low cost "bunker fuel". This is rather than having to switch to high-cost low sulphur gas oil for the life of the ship, while meeting the imminent IMO legislation in 2020 for ships to considerably reduce their emissions.

Pacific Green Technologies, Inc. (PGTK), closed Monday's trading session at $1.90, up 18.75%, on 200 volume with 1 trade. The average volume for the last 3 months is 1,330 and the stock's 52-week low/high is $0.40/$2.09.

chart

Wealth Minerals Ltd. (WMLLF)

TradingView, MarketWatch, and InvestorsHub reported on Wealth Minerals Ltd. (WMLLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wealth Minerals Ltd. is a mineral resource company listed on the OTCQB. It has interests in Canada, Mexico, Peru and Chile. The Company’s chief focus is the acquisition of Lithium projects in South America. This includes interests in the Maricunga Salar in Chile. So far, Wealth Minerals has positioned itself to develop the Aguas Calientes Norte, Pujsa and Quisquiro Salars in Chile (the Trinity Project), and to work alongside existing producers in the prolific Atacama Salar. Wealth Minerals is based in Vancouver, British Columbia.

Additionally, Wealth Minerals maintains a portfolio of precious and base metal exploration-stage projects. This portfolio includes the 100 percent Wealth Minerals-owned Coronado property in southern Chihuahua, Mexico that spans 9911 Ha. The portfolio also includes Yanamina (Peru) and Valsequillo (Mexico).

Wealth Minerals announced in November 2016 that its wholly-owned Chilean subsidiary (Wealth Chile) entered into a formal option agreement with Atacama Lithium SpA, where it has been given the exclusive right and option to acquire a 100 percent royalty-free interest in 144 exploration concessions referred to as the Proyecto Atacama Lithium project situated in the Atacama Salar in Region II of Antofagasta, northern Chile.

The Company’s Wealth Chile entered into a Letter of Intent (LOI) dated December 12, 2016 with arm’s length vendors. Therefore, it was given the exclusive right and option to acquire a 100 percent royalty-free interest in the mining concessions referred to as the Laguna Verde project. The Project comprises 23 Concessions for a total of 2,438 hectares. It is in Region III (Atacama), northern Chile.

Recently, Wealth Minerals reported that it received positive results from the completed transient electromagnetic and gravity geophysical surveys at the Laguna Verde project.

The Company also announced that it signed a Letter of Intent (LOI) with Atacama Lithium Chile SpA regarding the grant of an option to acquire additional exploration mining concessions with an aggregate area of around 6,300 hectares surrounding the Laguna Verde Project and consisting of the Salar Green and Union projects that, if exercised, would bring its total land position in and surrounding Laguna Verde to about 8,700 hectares.

This month, Wealth Minerals announced that it executed a binding letter agreement, where it or a Chilean subsidiary of Wealth was granted the option and right to acquire 49 percent of the issued and outstanding shares of San Antonio Sociedad Contractual Minera and a 24.5 percent beneficial interest in certain exploration and exploitation mining concessions, which comprise the Salares 7 Lithium project (the Seven Salars Project). The Property is a lithium brine asset portfolio presently owned 50 percent by Talison Lithium Ltd. and 50 percent by San Antonio. It has a total area of 39,400 hectares located over seven salars in Region II, northern Chile.

Additionally, this month, Wealth Minerals announced that it closed the non-brokered private placement announced on June 2, 2017 and June 29, 2017. It issued a total of 3,704,946 common shares, including shares issued pursuant to finder’s fees, at a price of $1.50 per share for gross proceeds of $5,483,459.

The intention of the net proceeds from the Placement are to fund option payments on its mineral property options, the costs for the review and assessment of additional potential lithium mineral property acquisitions in South America, exploration work on its existing projects, and for general and administrative expenses and working capital purposes.

Wealth Minerals Ltd. (WMLLF), closed Monday's trading session at $0.4907, up 2.66%, on 120,227 volume with 41 trades. The average volume for the last 3 months is 122,972 and the stock's 52-week low/high is $0.41/$1.85.

chart

The QualityStocks Company Corner

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada is set to legalize recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.02603, off by 3.59%, on 209,665 volume with 36 trades. The average volume for the last 3 months is 354,139 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

665 Energy (SSOF)

The QualityStocks Daily Newsletter would like to spotlight 665 Energy (SSOF).

Headquartered in Oklahoma City, 665 Energy (SSOF), formerly Sixty Six Oilfield Services, has been a leading industry expert in the drilling equipment sector of the oil and gas industry for nearly six decades. The company’s sales and rental department provides solutions for domestic and international markets with core offerings that include a wide variety of customized drilling rigs and other select equipment.

665 Energy recently completed the acquisition of Fluid End Sales, doing business as Five Star Rig and Supply, which was established as a family owned business in 1984. The company’s focus continues to be on supplying the oil industry with custom drilling rigs, heavy-weight drill pipe, drill collars, pup joints, pony collars, handling tools, tubing, casing, blow-out preventers, engines, compressors and other select equipment to customers worldwide through its facilities in Oklahoma, Germany and Dubai. The company’s services include the sale of new equipment, sale of refurbished and certified used equipment, as well as rental of oilfield equipment.

Immediate expansion plans include partnering with a rig debt financing company to fund the $40 million purchase of 11 identified oil drilling rigs that have already been appraised. This action represents an incredible opportunity to jumpstart the next phase of growth and expansion.

Company president and CEO Jason Clayton, who started at Five Star in 1993, has worked in and managed all areas of the company including customer growth and sales. Clayton will also remain as president of the subsidiary, Five Star Rig and Supply, and is supported by longtime key staff members including Jimmy Joslin, who has been with Five Star Rig since 1984 and will be responsible for orders processing, inventory control, delivery, logistics and supervision of custom projects such as rig and rig equipment refurbishment, testing and certification. Jim Frazier will assume the role of CFO as the company prepares for further growth and expansion.

According to a research report by Statista, the world’s oil and gas equipment industry is projected to be worth nearly USD$205 billion by 2020 (http://nnw.fm/BzFl8), and as the energy sector continues strong growth in 2018, 665 Energy is well positioned to capitalize on the global trend and will continue to be aggressive in the marketplace.

665 Energy (SSOF), closed the day's trading session at $0.0072, off by 1.37%, on 2,531,140 volume with 42 trades. The average volume for the last 3 months is 3,327,052 and the stock's 52-week low/high is $0.0006/$0.0199.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

A recent release from PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) shows that, in cannabinoid extraction technology, the health sciences company is getting it right. The company announced that, during its soluble gel drug delivery research and development program – the Sol-gel Program – it had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method – the Extraction Protocol – for the accurate and precise quantification of cannabinoids present in the extract (http://nnw.fm/wC7bs).

PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.085, up 30.77%, on 2,407,854 volume with 240 trades. The average volume for the last 3 months is 785,829 and the stock's 52-week low/high is $0.048/$0.20.

Recent News

chart

GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (GRBX) is pleased to announce it has successfully completed the transfer of all business and assets of its parent company onto GRBX books as planned. Operations continued normally during the transition without interruption and the company is on track to realize all previously announced business objectives on schedule. All assets transferred are wholly owned by GRBX. Also today, NetworkNewsWire released a report on the company detailing how GRBX this morning announced that it has successfully completed the transfer of all business and assets of its parent company onto GRBX’s books, as planned. To view the full press release, visit: http://nnw.fm/6zTE2.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.52, up 18.18%, on 31,556 volume with 23 trades. The average volume for the last 3 months is 47,861 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout Inc. (OTCPink: GOHE) (“Global”) and its wholly owned subsidiary MTrac Tech Corp. (“MTrac” or the “Company”) are pleased to announce that MGR2, LLC (“MGR2”), the government relations team engaged by the Company, has made significant strides in recent weeks to incorporate language regarding blockchain in State Assembly Bills to develop cashless ecosystems for legal marijuana businesses. Also today, NetworkNewsWire released a report on the company detailing how GOHE , alongside wholly owned subsidiary MTrac Tech Corp., this morning announced that MGR2, LLC, the government relations team engaged by the company, has made significant strides in recent weeks toward incorporating language regarding blockchain in state assembly bills to aid in the development of cashless ecosystems for legal cannabis businesses. To view the full press release, visit: http://nnw.fm/dSKw1.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0102, up 3.03%, on 4,827,805 volume with 148 trades. The average volume for the last 3 months is 5,209,401 and the stock's 52-week low/high is $0.0092/$0.459.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) and True Promise Beauty have announced the development of LYXR – a new line of cannabidiol (CBD)-based luxury skin and hair care products. The entire LYXR line will be developed from ingredients like hemp-derived phytocannabinoids and other natural components, according to a company announcement on September 20, 2018 (http://nnw.fm/b6dEU).

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.89, up 5.14%, on 44,275 volume with 141 trades. The average volume for the last 3 months is 101,716 and the stock's 52-week low/high is $0.0309/$7.13.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

SeeThruEquity, the leading independent equity research firm focused on smallcap and microcap public companies, today announced it has issued an update note on ChineseInvestors.com, Inc. (OTCQB: CIIX). The report is available here: CIIX Update Note.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.755, up 6.34%, on 745,449 volume with 402 trades. The average volume for the last 3 months is 286,262 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce the launch of its Beacon Medical™ website, its coverage of the excise tax on cannabis purchases, and an affiliation with Strainprint Technologies Ltd.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.27, up 0.79%, on 434,641 volume with 353 trades. The average volume for the last 3 months is 744,127 and the stock's 52-week low/high is $0.72/$3.29.

Recent News

chart

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (OTC: ZNGY) specializes in lessening utility consumption. A business-to-business (B2B) enterprise, the company provides retail energy, energy conservation, smart controls and efficiency-based products and services. Its corporate vision is to enhance businesses by way of responsible energy use and management. The company is based in Dallas, Texas.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0005, off by 16.67%, on 24,052,997 volume with 29 trades. The average volume for the last 3 months is 18,898,041 and the stock's 52-week low/high is $0.0045/$0.0299.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW) (“DPW”), a diversified holding company, today announced that its subsidiary, SpyGlass Hill Capital Lending, Corp. launched MonthlyInterest.com, an online portal that facilitates investments that pay monthly interest.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.4216, off by 1.10%, on 690,392 volume with 1,306 trades. The average volume for the last 3 months is 1,773,148 and the stock's 52-week low/high is $0.389/$5.949.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce the appointment of American businessman, investor, and television personality Tim Seymour to the Company's Advisory Board.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $6.47, up 1.01%, on 1,267,293 volume with 3,542 trades. The average volume for the last 3 months is 749,698 and the stock's 52-week low/high is $2.784/$7.893.

Recent News

chart

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Heart disease remains the leading cause of death in men and women within the United States (http://nnw.fm/zVc6d), accounting for one out of every four deaths, and, as such, is fertile ground for research that is published regularly in professional periodicals such as the Journal of the American Heart Association (http://nnw.fm/h6wiZ). The ailment is also the inspiration for a variety of business enterprises aiming to help the public reduce heart disease risks, and among those companies is health care technology company Zenosense, Inc. (OTCQB: ZENO), a co-owner of the United Kingdom’s MIDS Medical Limited (MML) and its innovative handheld MIDS technology, as implemented in the ongoing development of its MIDS Cardiac device.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.32, up 3.23%, on 30,101 volume with 26 trades. The average volume for the last 3 months is 121,464 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom") an emerging, fully-integrated cannabis company, is pleased to announce that it has been added to the Canadian Securities Exchange's ("CSE") CSE 25 Index ("the Index"), which became effective at the market close on Friday, September 21, 2018.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.92, off by 4.17%, on 414,143 volume with 383 trades. The average volume for the last 3 months is 305,919 and the stock's 52-week low/high is $0.18/$1.129.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (KBEVF).

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) (the "Company" or "Koios") is pleased to announce the Company has entered into an agreement (the "Agreement") for a draw-down equity facility of up to $28,000,000. The Agreement provides for equity private placement offerings (each, an "Offering"), to be conducted between the Company and Alumina Partners (Ontario) Ltd. ("Alumina Partners"), a subsidiary of Alumina Partners LLC, a New York based private equity firm that has made significant investments in the cannabis sector, in draw-down amounts of up to $2,000,000.

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEVF), closed the day's trading session at $0.57994, off by 22.05%, on 981,183 volume with 519 trades. The average volume for the last 3 months is 516,081 and the stock's 52-week low/high is $0.001/$0.8152.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.